[go: up one dir, main page]

MX2013009175A - Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas. - Google Patents

Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.

Info

Publication number
MX2013009175A
MX2013009175A MX2013009175A MX2013009175A MX2013009175A MX 2013009175 A MX2013009175 A MX 2013009175A MX 2013009175 A MX2013009175 A MX 2013009175A MX 2013009175 A MX2013009175 A MX 2013009175A MX 2013009175 A MX2013009175 A MX 2013009175A
Authority
MX
Mexico
Prior art keywords
compositions
peroxy
methods
same
producing
Prior art date
Application number
MX2013009175A
Other languages
English (en)
Inventor
Edwin D Neas
John D Skinner
Original Assignee
Chd Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chd Bioscience Inc filed Critical Chd Bioscience Inc
Publication of MX2013009175A publication Critical patent/MX2013009175A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C409/00—Peroxy compounds
    • C07C409/24—Peroxy compounds the —O—O— group being bound between a >C=O group and hydrogen, i.e. peroxy acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona composiciones que comprenden ácido peroxi alfa-cetocarboxílico y métodos para usarlos. En algunas modalidades particulares, composiciones de la invención también incluyen alfa-cetoésteres.
MX2013009175A 2011-02-17 2012-02-17 Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas. MX2013009175A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161444111P 2011-02-17 2011-02-17
US201161565986P 2011-12-02 2011-12-02
PCT/US2012/025736 WO2012112951A1 (en) 2011-02-17 2012-02-17 COMPOSITIONS COMPRISING PEROXY α-KETOCARBOXYLIC ACID AND METHODS FOR PRODUCING AND USING THE SAME

Publications (1)

Publication Number Publication Date
MX2013009175A true MX2013009175A (es) 2013-08-29

Family

ID=46652919

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009175A MX2013009175A (es) 2011-02-17 2012-02-17 Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.

Country Status (12)

Country Link
US (1) US20120213835A1 (es)
EP (2) EP3067051A1 (es)
JP (1) JP6291256B2 (es)
KR (1) KR20140008394A (es)
CN (1) CN103402509B (es)
AU (1) AU2012219321C1 (es)
BR (1) BR112013020767A2 (es)
CA (1) CA2826646A1 (es)
IL (1) IL227699A0 (es)
MX (1) MX2013009175A (es)
RU (1) RU2013142256A (es)
WO (1) WO2012112951A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280721A1 (en) 2003-06-03 2006-12-14 The Gov Of Usa Represented By Secretary Of Dpt Of Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
CN106038532B (zh) 2008-01-04 2019-05-14 牛津大学科技创新有限公司 用作降低血脂药剂的酮体和酮体酯
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
US8445717B2 (en) 2008-11-20 2013-05-21 Chd Bioscience, Inc. α-Keto alkylperacids and methods for producing and using the same
JP5694179B2 (ja) 2008-11-20 2015-04-01 シーエイチディー・バイオサイエンス，インコーポレーテッド α−ケト過酸並びにそれを製造する方法及び使用する方法
US11006629B2 (en) 2008-11-20 2021-05-18 Armis Biopharma, Inc. Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
US11284621B2 (en) 2010-04-15 2022-03-29 Armis Biopharma, Inc. Compositions comprising peroxyacid and methods for producing and using the same
US9044527B2 (en) 2011-02-17 2015-06-02 Chd Bioscience, Inc. Wound care products with peracid compositions
CN104902954B (zh) * 2012-08-14 2018-01-23 Chd生物科学公司 具有过酸组合物的伤口护理产品
CN104619320A (zh) * 2012-09-14 2015-05-13 宝丽制药股份有限公司 含有卢立康唑的药物组合物
NZ707113A (en) * 2012-10-18 2016-07-29 Chd Bioscience Inc Compositions comprising peroxy acid
DK2914251T3 (da) 2012-11-05 2019-11-04 Us Health Ketonlegemer til beskyttelse af væv mod beskadigelse som følge af ioniseringsstråling
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
EP2984066B1 (en) 2013-03-14 2017-02-01 Oxford University Innovation Limited Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
WO2015120216A1 (en) 2014-02-07 2015-08-13 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
US11878106B2 (en) * 2015-12-29 2024-01-23 3M Innovative Properties Company System and methods for the treatment of wounds with negative pressure and instillation of peroxide pyruvic acid
JP7065774B2 (ja) * 2015-12-29 2022-05-12 スリーエム イノベイティブ プロパティズ カンパニー 負圧およびペルオキシピルビン酸を用いる創傷の治療のためのシステムおよび方法
MX2018008947A (es) 2016-03-22 2018-11-09 Stepan Co Peroxi acidos no alfa sustituidos y usos de los mismos.
WO2019010465A1 (en) * 2017-07-07 2019-01-10 Armis Biopharma, Inc. ANTIMICROBIAL, DISINFECTANT AND HEALING COMPOSITIONS AND METHODS OF MAKING AND USING SAME
US20210077438A1 (en) 2017-07-07 2021-03-18 Armis Biopharma, Inc. Compositions and methods for remediating chemical warfare agent exposure and surface decontamination
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020197883A1 (en) 2019-03-27 2020-10-01 Kci Licensing, Inc. System and methods for the treatment of wounds with negative pressure and instillation of peroxide pyruvic acid
WO2025135003A1 (ja) * 2023-12-22 2025-06-26 小林製薬株式会社 抗菌又は抗ウイルス剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0614359A1 (en) * 1991-11-26 1994-09-14 Warner-Lambert Company Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
DE4444237C2 (de) * 1994-12-13 2000-08-24 Beiersdorf Ag Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne
JP2004528307A (ja) * 2001-03-15 2004-09-16 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション サイトカインにより媒介される炎症性状態の治療のためのピルベートおよび／またはその誘導体の使用方法
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
WO2004095921A2 (en) * 2002-11-01 2004-11-11 Mionix Corporation Sporicidal composition
WO2006108680A2 (en) * 2005-04-15 2006-10-19 Biomac Privatinstitut Für Medizinische Und Zahnmedizinische Forschung, Entwicklung Und Diagnostik Gmbh Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against protozoa and helminthes
US8815946B2 (en) * 2008-01-25 2014-08-26 University of Pittsburgh—of the Commonwealth System of Higher Education Inhibition of proliferation and fibrotic response of activated corneal stromal cells
US8034759B2 (en) * 2008-10-31 2011-10-11 Ecolab Usa Inc. Enhanced stability peracid compositions
US8445717B2 (en) * 2008-11-20 2013-05-21 Chd Bioscience, Inc. α-Keto alkylperacids and methods for producing and using the same
JP5694179B2 (ja) * 2008-11-20 2015-04-01 シーエイチディー・バイオサイエンス，インコーポレーテッド α−ケト過酸並びにそれを製造する方法及び使用する方法
WO2011129829A1 (en) * 2010-04-15 2011-10-20 Chata Biosystems, Inc. α-KETO ALKYLPERACIDS AND METHODS FOR PRODUCING AND USING THE SAME

Also Published As

Publication number Publication date
EP2675441A1 (en) 2013-12-25
EP2675441A4 (en) 2014-12-31
AU2012219321C1 (en) 2016-02-04
AU2012219321A1 (en) 2013-03-28
US20120213835A1 (en) 2012-08-23
BR112013020767A2 (pt) 2016-10-11
JP6291256B2 (ja) 2018-03-14
KR20140008394A (ko) 2014-01-21
WO2012112951A1 (en) 2012-08-23
CN103402509B (zh) 2016-04-13
CN103402509A (zh) 2013-11-20
EP3067051A1 (en) 2016-09-14
CA2826646A1 (en) 2012-08-23
JP2014513056A (ja) 2014-05-29
RU2013142256A (ru) 2015-03-27
IL227699A0 (en) 2013-09-30
AU2012219321B2 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
MX349630B (es) Alfa-amilasas.
MY178142A (en) Anti-phf-tau antibodies and their uses
MX361862B (es) Composiciones y métodos que comprenden variante de enzima lipolítica.
EA201391602A1 (ru) Контролируемое высвобождение иммунодепрессантов из синтетических наноносителей
PH12013500360B1 (en) Pesticidal compositions
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
PH12014501158A1 (en) Composition comprising a shelf-life stability component
MX340323B (es) Composiciones formadoras de gel in situ.
JO3755B1 (ar) تركيبات تستوستيرون
MX2013004981A (es) Composiciones y metodos para la administracion de agentes terapeuticos.
MY155330A (en) Methods for salt production
MX337203B (es) Novedosas moleculas inhbidoras de jnk.
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
PH12013500500A1 (en) Fused heteroaryls and their uses
MY161601A (en) Films and compositions comprising the same
WO2014097318A3 (en) Agents for eliminating tumour-initiating cells
MX358132B (es) Solucion de trombina y metodos de uso de esta.
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
MX352620B (es) Polimeros de condensacion de acido mandelico.
PH12012501547A1 (en) Methods of preparing thiazolidines
MX2012012509A (es) Tapentadol para usarse en el tratamiento del sindrome del intestino irritable.
PH12014500432A1 (en) Stable compositions and methods for preparing the same
UA106373C2 (ru) Применение поллентара как средства фригопротекторного действия

Legal Events

Date Code Title Description
FA Abandonment or withdrawal